CARRIER, TESLA, AND INDUSTRY LEADERS INITIATE EFFORT TO REDUCE ELECTRICITY EXPENSES BY TAP INTO UNTAPPED GRID CAPACITY
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 10 2026
0mins
Should l Buy TSLA?
Source: moomoo
Campaign Launch: Carrier, Tesla, and industry leaders have initiated a campaign aimed at reducing electric city costs.
Unlocking Grid Capacity: The focus of the campaign is to unlock underused grid capacity to achieve lower electricity costs for consumers.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TSLA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TSLA
Wall Street analysts forecast TSLA stock price to rise
30 Analyst Rating
12 Buy
11 Hold
7 Sell
Hold
Current: 355.280
Low
25.28
Averages
401.93
High
600.00
Current: 355.280
Low
25.28
Averages
401.93
High
600.00
About TSLA
Tesla, Inc. designs, develops, manufactures, sells and leases high-performance fully electric vehicles and energy generation and storage systems, and offers services related to its products. Its segments include automotive, and energy generation and storage. The automotive segment includes the design, development, manufacturing, sales and leasing of high-performance fully electric vehicles, and sales of automotive regulatory credits. It also includes sales of used vehicles, non-warranty maintenance services and collisions, part sales, paid supercharging, insurance services revenue and retail merchandise sales. The energy generation and storage segment include the design, manufacture, installation, sales and leasing of solar energy generation and energy storage products and related services and sales of solar energy systems incentives. Its consumer vehicles include the Model 3, Y, S, X and Cybertruck. Its lithium-ion battery energy storage products include Powerwall and Megapack.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Tesla Faces Tough Start to 2026 with Declining Deliveries and Margins
- Significant Stock Decline: Tesla's stock has lost over 20% since the beginning of 2026, currently trading around $356, which may attract investor interest but also signals potential further downside risks.
- Declining Delivery Expectations: The company is expected to deliver approximately 366,000 vehicles in Q1 2026, representing a 9% year-over-year increase, yet a 13% sequential drop from 418,227 vehicles in Q4 2025, indicating serious challenges in delivery performance.
- Deteriorating Profitability: Tesla's latest operating margin fell to 5.7%, down from 6.2% year-over-year, and earnings per share plummeted 60% to $0.24, highlighting the company's financial struggles amid fierce competition and pricing pressures.
- Increased Capital Expenditures: With capital expenditures reaching $8.5 billion in 2025 and expected to rise in 2026, these investments may offer long-term growth opportunities but significantly elevate the company's risk profile.
See More
Tesla and BYD Electric Vehicle Market Competition Analysis
- Sales Comparison: BYD produced 2.22 million passenger EVs last year, a 25% increase, while Tesla produced 1.65 million; although Tesla remains a market leader, BYD's rapid growth could impact Tesla's market share.
- Delivery Data: BYD's EV deliveries reached 2.26 million, up nearly 28%, while Tesla's deliveries fell by 9%, indicating BYD's superior performance in meeting market demand, posing a threat to Tesla's sales.
- Technological Innovation: BYD introduced a fast-charging battery that can charge from 20% to 97% in just 12 minutes even in extreme temperatures, which may attract more price-sensitive consumers and enhance its competitive edge.
- Strategic Shift: Tesla plans to utilize vacant space in its Fremont, California factory to produce AI-powered Optimus humanoid robots; while this strategic pivot may present new growth opportunities, it also carries execution risks, especially given its high valuation, necessitating cautious evaluation by investors regarding its long-term outlook.
See More
US Stocks Surge as Market Sentiment Improves
- Market Rebound: The S&P 500 Index rose by 1.33%, the Dow Jones Industrial Average increased by 1.10%, and the Nasdaq 100 Index climbed by 1.45%, reflecting investor optimism following President Trump's willingness to end military actions against Iran, potentially easing geopolitical tensions.
- Supportive Economic Data: China's March manufacturing PMI rose by 1.4 to 50.4, surpassing expectations of 50.1, indicating signs of economic recovery that could enhance global growth prospects and drive stock markets higher.
- Falling Bond Yields: The 10-year T-note yield dropped to 4.30%, a one-week low, as WTI crude oil prices fell, alleviating inflation concerns and lowering borrowing costs, thereby supporting further gains in the stock market.
- Tech Stocks Lead Gains: The
See More
Wall Street's Latest Ratings Overview
- Visa and Mastercard Ratings: Loop initiates coverage on Visa and Mastercard with a buy rating, anticipating significant net revenue growth driven by market share gains and upside from foreign exchange volatility, enhancing their competitive edge in the payment processing sector.
- Arista and Cisco Buy Ratings: Truist initiates buy ratings for Arista Networks and Cisco, citing their high-quality business scale and thematic attractiveness, particularly in the data center growth space, which presents underappreciated opportunities.
- 10X Genomics Upgrade: William Blair upgrades 10X Genomics from market perform to outperform, highlighting its pivotal role in AI drug discovery and improved profitability, which is expected to drive future growth following five consecutive topline beats.
- MiniMed Platform Outlook: Morgan Stanley initiates MiniMed at overweight with a $19 price target, projecting that its differentiated diabetes management platform will drive growth and margin expansion, particularly given the significant underpenetration in the U.S. market.
See More
The 'Magnificent Seven' Stocks Struggle Amid AI Spending Concerns
- ETF Performance Decline: The Roundhill Magnificent Seven ETF has fallen over 9% this year, significantly underperforming the broader market, leading investors to potentially view it as a buying opportunity, though valuation considerations remain critical.
- Surge in Capital Expenditures: The Magnificent Seven are projected to spend nearly $700 billion on capital expenditures in 2025, raising concerns among investors about the ability of these companies to deliver strong returns on such massive investments, which has contributed to declining valuations across the group.
- Lowest Valuation for Meta: Meta Platforms currently trades at less than 20 times forward earnings, with a projected 73% increase in capital expenditures for 2026 aimed at supporting AI infrastructure, although its advertising business could benefit from AI applications.
- Investor Confidence Wavers: Despite Meta's success in advertising revenue, investors are concerned about Zuckerberg's investment strategy in AI, particularly after significant losses in its metaverse division, highlighting the need for disciplined investment approaches.
See More
Investors at a Crossroads with AI: Concerns and Opportunities
- Investor Anxiety: While investors remain optimistic about AI's potential, there are concerns regarding the significant spending on AI infrastructure by the 'Magnificent Seven,' with projected capital expenditures nearing $700 billion in 2025, leading to a decline in overall valuations.
- Meta's Low Valuation: Meta Platforms is currently trading at a PE ratio of less than 20 times forward earnings, with projected capital expenditures for 2026 ranging from $115 billion to $135 billion, a 73% increase from last year, primarily aimed at supporting AI infrastructure, raising concerns about investment returns.
- Advertising Business Potential: Meta reported a 24% year-over-year increase in advertising revenue in 2025, highlighting AI's potential in enhancing ad targeting, although investors are wary of Zuckerberg's investment strategies, especially following his significant bet on the metaverse.
- Alphabet's Success: Alphabet's stock has risen over 75% in the past year, successfully overcoming a high-profile lawsuit from the U.S. Department of Justice, demonstrating the competitiveness of its AI models and positioning itself as a value investment choice within the 'Magnificent Seven,' attracting investor interest.
See More
Tesla Faces Tough Start to 2026 with Declining Deliveries and Margins
- Significant Stock Decline: Tesla's stock has lost over 20% since the beginning of 2026, currently trading around $356, which may attract investor interest but also signals potential further downside risks.
- Declining Delivery Expectations: The company is expected to deliver approximately 366,000 vehicles in Q1 2026, representing a 9% year-over-year increase, yet a 13% sequential drop from 418,227 vehicles in Q4 2025, indicating serious challenges in delivery performance.
- Deteriorating Profitability: Tesla's latest operating margin fell to 5.7%, down from 6.2% year-over-year, and earnings per share plummeted 60% to $0.24, highlighting the company's financial struggles amid fierce competition and pricing pressures.
- Increased Capital Expenditures: With capital expenditures reaching $8.5 billion in 2025 and expected to rise in 2026, these investments may offer long-term growth opportunities but significantly elevate the company's risk profile.
See More
Tesla and BYD Electric Vehicle Market Competition Analysis
- Sales Comparison: BYD produced 2.22 million passenger EVs last year, a 25% increase, while Tesla produced 1.65 million; although Tesla remains a market leader, BYD's rapid growth could impact Tesla's market share.
- Delivery Data: BYD's EV deliveries reached 2.26 million, up nearly 28%, while Tesla's deliveries fell by 9%, indicating BYD's superior performance in meeting market demand, posing a threat to Tesla's sales.
- Technological Innovation: BYD introduced a fast-charging battery that can charge from 20% to 97% in just 12 minutes even in extreme temperatures, which may attract more price-sensitive consumers and enhance its competitive edge.
- Strategic Shift: Tesla plans to utilize vacant space in its Fremont, California factory to produce AI-powered Optimus humanoid robots; while this strategic pivot may present new growth opportunities, it also carries execution risks, especially given its high valuation, necessitating cautious evaluation by investors regarding its long-term outlook.
See More
US Stocks Surge as Market Sentiment Improves
- Market Rebound: The S&P 500 Index rose by 1.33%, the Dow Jones Industrial Average increased by 1.10%, and the Nasdaq 100 Index climbed by 1.45%, reflecting investor optimism following President Trump's willingness to end military actions against Iran, potentially easing geopolitical tensions.
- Supportive Economic Data: China's March manufacturing PMI rose by 1.4 to 50.4, surpassing expectations of 50.1, indicating signs of economic recovery that could enhance global growth prospects and drive stock markets higher.
- Falling Bond Yields: The 10-year T-note yield dropped to 4.30%, a one-week low, as WTI crude oil prices fell, alleviating inflation concerns and lowering borrowing costs, thereby supporting further gains in the stock market.
- Tech Stocks Lead Gains: The
See More
Wall Street's Latest Ratings Overview
- Visa and Mastercard Ratings: Loop initiates coverage on Visa and Mastercard with a buy rating, anticipating significant net revenue growth driven by market share gains and upside from foreign exchange volatility, enhancing their competitive edge in the payment processing sector.
- Arista and Cisco Buy Ratings: Truist initiates buy ratings for Arista Networks and Cisco, citing their high-quality business scale and thematic attractiveness, particularly in the data center growth space, which presents underappreciated opportunities.
- 10X Genomics Upgrade: William Blair upgrades 10X Genomics from market perform to outperform, highlighting its pivotal role in AI drug discovery and improved profitability, which is expected to drive future growth following five consecutive topline beats.
- MiniMed Platform Outlook: Morgan Stanley initiates MiniMed at overweight with a $19 price target, projecting that its differentiated diabetes management platform will drive growth and margin expansion, particularly given the significant underpenetration in the U.S. market.
See More
The 'Magnificent Seven' Stocks Struggle Amid AI Spending Concerns
- ETF Performance Decline: The Roundhill Magnificent Seven ETF has fallen over 9% this year, significantly underperforming the broader market, leading investors to potentially view it as a buying opportunity, though valuation considerations remain critical.
- Surge in Capital Expenditures: The Magnificent Seven are projected to spend nearly $700 billion on capital expenditures in 2025, raising concerns among investors about the ability of these companies to deliver strong returns on such massive investments, which has contributed to declining valuations across the group.
- Lowest Valuation for Meta: Meta Platforms currently trades at less than 20 times forward earnings, with a projected 73% increase in capital expenditures for 2026 aimed at supporting AI infrastructure, although its advertising business could benefit from AI applications.
- Investor Confidence Wavers: Despite Meta's success in advertising revenue, investors are concerned about Zuckerberg's investment strategy in AI, particularly after significant losses in its metaverse division, highlighting the need for disciplined investment approaches.
See More
Investors at a Crossroads with AI: Concerns and Opportunities
- Investor Anxiety: While investors remain optimistic about AI's potential, there are concerns regarding the significant spending on AI infrastructure by the 'Magnificent Seven,' with projected capital expenditures nearing $700 billion in 2025, leading to a decline in overall valuations.
- Meta's Low Valuation: Meta Platforms is currently trading at a PE ratio of less than 20 times forward earnings, with projected capital expenditures for 2026 ranging from $115 billion to $135 billion, a 73% increase from last year, primarily aimed at supporting AI infrastructure, raising concerns about investment returns.
- Advertising Business Potential: Meta reported a 24% year-over-year increase in advertising revenue in 2025, highlighting AI's potential in enhancing ad targeting, although investors are wary of Zuckerberg's investment strategies, especially following his significant bet on the metaverse.
- Alphabet's Success: Alphabet's stock has risen over 75% in the past year, successfully overcoming a high-profile lawsuit from the U.S. Department of Justice, demonstrating the competitiveness of its AI models and positioning itself as a value investment choice within the 'Magnificent Seven,' attracting investor interest.
See More
